$213.57
+1.8%STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
President, Chief Executive Officer & Director
Compensation
$2,284,218
SVP & Chief Human Resources Officer
Compensation
$725,668
Senior Vice President & GM of AST
Senior Vice President & GM of Dental
Compensation
$1,438,246
Senior Vice President & GM of Life Sciences
Senior Vice President & President of Healthcare
Compensation
$861,813
Senior Vice President, Chief Financial Officer & Chief Accounting Officer
Senior Vice President, General Counsel & Secretary
Compensation
$943,792
VP, Chief Compliance & Quality Officer
Vice President of Investor Relations & Corporate Communications
During the last 12 months, insiders have sold $2.15M worth of STE shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
3.1K
734.88K
-735K
-$735K
0
0.00
5.5K
1.42M
-1.4M
-$1.42M
0
0.00
0
0.00
+0
+$0
No buying activity
Tamaro Renato
Officer: V.P. & Corporate Treasurer
$856K
Feldmann Cynthia L
Director
$735K
Madsen Julia
Officer: Sr. Vp And Gm, Life Sciences
$560K
Strong bearish signal with $2.15M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
STE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | June 12, 2025 | July 31, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | June 12, 2024 | August 01, 2024 | 2024 | |
DEF 14A DEF 14A N/A | June 07, 2023 | June 07, 2023 | ||
DEF 14A DEF 14A 2022 N/A | June 07, 2022 | July 28, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | June 07, 2021 | July 29, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | June 05, 2020 | July 28, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | June 05, 2019 | July 30, 2019 | 2019 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.